Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico
Clinical trial NCT03161613 · WITHDRAWN
Trial details
- NCT number
- NCT03161613
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-07-17
- Primary completion
- 2019-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.